36 primary sources

Check our work.

Provider pages, manufacturer terms, FDA information and prescribing labels. Every listing links back to its evidence.

Follow the evidence

Sources & price notes

Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.

  1. CoreAge Rx — treatment catalog ↗

    Official public information; price and terms checked October 8, 2026.

  2. CoreAge Rx — product and plan terms ↗

    Official public information; price and terms checked October 8, 2026.

  3. CoreAge Rx — Compounded semaglutide ↗

    Official public information; price and terms checked October 8, 2026.

  4. CoreAge Rx — Compounded tirzepatide ↗

    Official public information; price and terms checked October 8, 2026.

  5. CoreAge Rx — Sermorelin ↗

    Official public information; price and terms checked October 8, 2026.

  6. CoreAge Rx — NAD+ injection ↗

    Official public information; price and terms checked October 8, 2026.

  7. CoreAge Rx — NAD+ nasal ↗

    Official public information; price and terms checked October 8, 2026.

  8. CoreAge Rx — Bounce Back ↗

    Official public information; price and terms checked October 8, 2026.

  9. OrderlyMeds — full pricing ↗

    Official public information; price and terms checked October 8, 2026.

  10. Mochi Health — pricing FAQ ↗

    Official public information; price and terms checked October 8, 2026.

  11. Henry Meds — program pricing and commitments ↗

    Official public information; price and terms checked October 8, 2026.

  12. Henry Meds — advertised weight management plans ↗

    Official public information; price and terms checked October 8, 2026.

  13. Ro — membership and medication prices ↗

    Official public information; price and terms checked October 8, 2026.

  14. AgelessRx — Sermorelin ↗

    Official public information; price and terms checked October 8, 2026.

  15. AgelessRx — NAD+ injection ↗

    Official public information; price and terms checked October 8, 2026.

  16. AgelessRx — Glutathione injection ↗

    Official public information; price and terms checked October 8, 2026.

  17. AgelessRx — Glutathione nasal spray ↗

    Official public information; price and terms checked October 8, 2026.

  18. AgelessRx — glutathione introductory and recurring prices ↗

    Official public information; price and terms checked October 8, 2026.

  19. Strut Health — sermorelin pricing ↗

    Official public information; price and terms checked October 8, 2026.

  20. Strut Health — wellness catalog ↗

    Official public information; price and terms checked October 8, 2026.

  21. FDA — Strut Health warning letter, February 20, 2026 ↗

    Published letter about compounded GLP-1 marketing; subsequent regulatory status is not established by this review.

  22. Eden — NAD+ plans and inclusions ↗

    Official public information; price and terms checked October 8, 2026.

  23. Ivím — individualized GLP-1 program ↗

    Official public information; price and terms checked October 8, 2026.

  24. Lilly — Zepbound self-pay and savings terms ↗

    Official public information; price and terms checked October 8, 2026.

  25. Lilly — Foundayo self-pay and savings terms ↗

    Official public information; price and terms checked October 8, 2026.

  26. NovoCare — Wegovy pricing by formulation ↗

    Official public information; price and terms checked October 8, 2026.

  27. The Ordinary — Multi-Peptide + Copper Peptides 1% ↗

    Official public information; price and terms checked October 8, 2026.

  28. NIOD — Copper Amino Isolate Lipid 1% ↗

    Official public information; price and terms checked October 8, 2026.

  29. Vyleesi — access, eligibility and safety ↗

    Official public information; price and terms checked October 8, 2026.

  30. FDA — compounding questions and answers ↗

    Clinical and regulatory context. A compounded preparation is not FDA-approved.

  31. FDA — concerns with unapproved GLP-1 drugs ↗

    Safety, dosing errors, salt forms and misleading online marketing.

  32. FDA — ingredients for sterile compounding ↗

    NAD+ adverse-event reports and ingredient-quality concerns; not a finding about any listed provider.

  33. FDA — compounding substances with potential safety risks ↗

    Includes injectable GHK-Cu; route-specific concerns must not be applied indiscriminately to cosmetics.

  34. FDA — Foundayo approval, April 1, 2026 ↗

    Approval and indicated population; a non-peptide GLP-1 medicine.

  35. Wegovy — prescribing information ↗

    Formulation-specific approved uses, contraindications and warnings.

  36. Zepbound — prescribing information ↗

    Approved uses, contraindications and warnings.